Balchem Corp (BCPC)
178.03
+0.50
(+0.28%)
USD |
NASDAQ |
Nov 20, 16:00
179.42
+1.39
(+0.78%)
Pre-Market: 08:06
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.787B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 44.26% |
| Valuation | |
| PE Ratio | 47.86 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 6.165 |
| Price to Book Value | 4.916 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.79 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1928 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 33.89% |
Profile
| Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 25, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2023 |
Ratings
Profile
| Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 14, 2025 (est.) |
| Last Earnings Release | Oct. 25, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2023 |